Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
The effect of PARP inhibitors on bone mass and bone metastasis are unclear. Here, the authors show that PARP1/2 dual inhibitors may increase cancer bone metastasis through PARP2-dependent regulation of immature myeloid cells, and cause bone loss through PARP1/2-dependent regulation of osteoclasts.
Guardado en:
Autores principales: | Hao Zuo, Dengbao Yang, Qiwen Yang, Haidong Tang, Yang-Xin Fu, Yihong Wan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ab0627a85d644db82a8b2b8a0f4f8d7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
por: Hyoung Kim, et al.
Publicado: (2020) -
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
por: Hiroshi Iwata, et al.
Publicado: (2016) -
Serine-linked PARP1 auto-modification controls PARP inhibitor response
por: Evgeniia Prokhorova, et al.
Publicado: (2021) -
Dual function of HPF1 in the modulation of PARP1 and PARP2 activities
por: Tatyana A. Kurgina, et al.
Publicado: (2021) -
SPINDOC binds PARP1 to facilitate PARylation
por: Fen Yang, et al.
Publicado: (2021)